Public procurement notice: Contract Notice
Published: 2020-05-07
Buyer: The NHS Commissioning Board (operating under the name of NHS England)
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products | 33690000
Estimated value: 8663012 GBP
Submission deadline: 2020-05-20
Award criteria: The most economic tender

Technical requirements: Invitation to offer for NHS National Framework Agreement for the Supply of Generic Pharmaceuticals – Interim 1 2020
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months (12 months plus options to extend (at the Authority's sole discretion) for up to a further 12 months)
Invitation to offer for NHS National Framework Agreement for the Supply of Generic Pharmaceuticals – Interim 1 2020
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months (12 months plus options to extend (at the Authority's sole discretion) for up to a further 12 months)
Interim 1 2020 — Hospital Only Products: DLN/DCE/DSW Regions 1 August 2020 to 31 July 2021 (12 Months)
Period of framework agreement: the total maximum duration of the framework agreement to be no more than 24 months (12 months plus options to extend (at the Authority's sole discretion) for up to a further 12 months)
The Covid-19 outbreak has given rise to an urgent need for the supply of certain generic hospital only medicines where suppliers have terminated or previous tenders have been unable to secure supply, to avoid NHS resources being diverted to source alternative products and ensure continuity. This does not give sufficient time to comply with the standard open procedure timescales for this procurement. The Commercial Medicines Unit considers this to be a state of urgency which it has duly substantiated. Accordingly, the Commercial Medicines Unit is using the accelerated time limits permitted under the Public Contract Regulations 2015 (Regulation [27(5) for the open in respect of this procurement.
This procurement exercise will be conducted on the eTendering portal at https://nhsengland.bravosolution.co.uk
Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested), through the eTendering portal as follows:
1.1) If not already registered, Candidates should register on the eTendering portal at https://nhsengland.bravosolution.co.uk/web/login.html and click the link to register:
(d) access listing related to this procurement, NHS National Generics Pharmaceuticals Interim 1 2020 and view details;
(f) Once you have expressed interest, the ITT will move to ‘My ITTs’, where you can download additional documentation (if required), and construct your reply as instructed. You must then publish your reply using the ‘Publish’ button.
1.3) For any support in registering on the portal or submitting your expression of interest please contact the eTendering Help-desk at +44 800 368 4850 or help@bravosolution.co.uk
To manage and assess supplier information the contracting authority requests candidates provide their company profile in the Government's Supplier Registration Service (which has replaced sid4gov), as follows:
2.1) If not already registered (the previous sid4gov password, login and details will still be on the system), candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.uk and select ‘Register’ at the top of the page. Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&B. Candidates must obtain a Dun and Bradstreet (D&B) D-U-N-S® Number to enable registration on the system.


Award value: 8663012